{"id":533,"date":"2024-01-17T21:20:09","date_gmt":"2024-01-17T19:20:09","guid":{"rendered":"https:\/\/demo.artureanec.com\/themes\/neuros\/?page_id=533"},"modified":"2024-01-17T21:20:09","modified_gmt":"2024-01-17T19:20:09","slug":"blog-classic","status":"publish","type":"page","link":"https:\/\/www.tabukpharmaceuticals.com\/ar\/blog-classic\/","title":{"rendered":"Blog Classic"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"533\" class=\"elementor elementor-533\">\n\t\t\t\t\t\t<section data-particle_enable=\"false\" data-particle-mobile-disabled=\"false\" class=\"elementor-section elementor-top-section elementor-element elementor-element-5d02c5f elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"5d02c5f\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-20157d0\" data-id=\"20157d0\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-40538fd listing-pagination-border-style-gradient listing-pagination-background-style-solid elementor-widget elementor-widget-neuros_blog_listing\" data-id=\"40538fd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"neuros_blog_listing.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\n        <div class=\"archive-listing\" data-ajax='{&quot;post_type&quot;:&quot;post&quot;,&quot;posts_per_page&quot;:4,&quot;orderby&quot;:&quot;date&quot;,&quot;order&quot;:&quot;desc&quot;,&quot;paged&quot;:1,&quot;category_name&quot;:&quot;&quot;,&quot;tag&quot;:&quot;&quot;,&quot;post__in&quot;:&quot;&quot;,&quot;ignore_sticky_posts&quot;:false,&quot;link_base&quot;:&quot;https:\\\/\\\/www.tabukpharmaceuticals.com\\\/ar\\\/wp-json\\\/wp\\\/v2\\\/pages\\\/533&quot;}' data-widget='{&quot;listing_type&quot;:&quot;classic&quot;,&quot;excerpt_length&quot;:218,&quot;show_cat&quot;:&quot;yes&quot;,&quot;show_media&quot;:&quot;yes&quot;,&quot;show_author&quot;:&quot;yes&quot;,&quot;show_date&quot;:&quot;yes&quot;,&quot;show_title&quot;:&quot;yes&quot;,&quot;show_tags&quot;:&quot;no&quot;,&quot;show_excerpt&quot;:&quot;yes&quot;,&quot;show_read_more&quot;:&quot;&quot;,&quot;read_more_text&quot;:&quot;Read More&quot;,&quot;columns_number&quot;:1,&quot;show_pagination&quot;:&quot;yes&quot;,&quot;item_class&quot;:&quot;post standard-blog-item-wrapper&quot;}'>\n            <div class=\"archive-listing-wrapper classic-listing\">\n                \r\n<div class=\"standard-blog-item-wrapper post post-31395 type-post status-publish format-standard has-post-thumbnail hentry category-press-releases\">\r\n    <div class=\"blog-item\">\r\n        <div class=\"post-media-wrapper\"><a href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/tabuk-pharmaceuticals-announces-exclusive-partnership-with-polaris-pharmaceuticals-to-introduce-adi-peg20-an-innovative-first-in-class-arginine-degradation-platform-for-hard-to-treat-cancers-in-the-k\/\"><picture><source media=\"(max-width: 575px)\" sizes=\"(max-width: 575px) 575px\" srcset=\"https:\/\/www.tabukpharmaceuticals.com\/wp-content\/uploads\/2025\/06\/image1-575x274.jpg 575w\"><source media=\"(max-width: 991px)\" sizes=\"(max-width: 991px) 991px\" srcset=\"https:\/\/www.tabukpharmaceuticals.com\/wp-content\/uploads\/2025\/06\/image1-991x472.jpg 991w\"><img decoding=\"async\" alt=\"image1\" title=\"image1\" src=\"https:\/\/www.tabukpharmaceuticals.com\/wp-content\/uploads\/2025\/06\/image1-1080x638.jpg\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" \/><\/picture><\/a><\/div><div class=\"post-meta-header\"><div class=\"post-meta-items-wrapper\"><div class=\"post-meta-items\"><div class=\"post-meta-item post-meta-item-date\"><a href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/2025\/06\/10\/\">\u064a\u0648\u0646\u064a\u0648 10, 2025<\/a><\/div><div class=\"post-meta-item post-meta-item-author\"><a href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/author\/ilyes\/\">Ilyes Haddad<\/a><\/div><\/div><\/div><\/div><h3 class=\"post-title\"><a href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/tabuk-pharmaceuticals-announces-exclusive-partnership-with-polaris-pharmaceuticals-to-introduce-adi-peg20-an-innovative-first-in-class-arginine-degradation-platform-for-hard-to-treat-cancers-in-the-k\/\">Tabuk Pharmaceuticals Announces Exclusive Partnership with Polaris Pharmaceuticals to introduce ADI-PEG20, an innovative First in class arginine degradation platform for hard-to-treat cancers in the Kingdom of Saudi Arabia and GCC Region.<\/a><\/h3><div class=\"post-content\">Strategic Collaboration to Address Critical Healthcare Needs and Expand Access to Life-Changing Treatments Riyadh \u2013 Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial Group), a l<\/div><div class=\"post-labels\"><div class=\"post-categories\"><a class=\"post-category-item\" href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/category\/press-releases\/\">Press Releases<\/a><\/div><\/div>    <\/div>\r\n<\/div>\r\n<div class=\"standard-blog-item-wrapper post post-31397 type-post status-publish format-standard has-post-thumbnail hentry category-press-releases\">\r\n    <div class=\"blog-item\">\r\n        <div class=\"post-media-wrapper\"><a href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/tabuk-pharmaceuticals-expands-strategic-partnership-with-hk-inno-n-to-include-additional-mena-markets-for-k-cab-tegoprazan\/\"><picture><source media=\"(max-width: 575px)\" sizes=\"(max-width: 575px) 575px\" srcset=\"https:\/\/www.tabukpharmaceuticals.com\/wp-content\/uploads\/2025\/04\/\u062a\u0646\u0632\u064a\u0644-13-575x274.jpg 575w\"><source media=\"(max-width: 991px)\" sizes=\"(max-width: 991px) 991px\" srcset=\"https:\/\/www.tabukpharmaceuticals.com\/wp-content\/uploads\/2025\/04\/\u062a\u0646\u0632\u064a\u0644-13-991x472.jpg 991w\"><img decoding=\"async\" alt=\"\u062a\u0646\u0632\u064a\u0644 (13)\" title=\"\u062a\u0646\u0632\u064a\u0644 (13)\" src=\"https:\/\/www.tabukpharmaceuticals.com\/wp-content\/uploads\/2025\/04\/\u062a\u0646\u0632\u064a\u0644-13-1080x638.jpg\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" \/><\/picture><\/a><\/div><div class=\"post-meta-header\"><div class=\"post-meta-items-wrapper\"><div class=\"post-meta-items\"><div class=\"post-meta-item post-meta-item-date\"><a href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/2025\/05\/07\/\">\u0645\u0627\u064a\u0648 7, 2025<\/a><\/div><div class=\"post-meta-item post-meta-item-author\"><a href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/author\/ilyes\/\">Ilyes Haddad<\/a><\/div><\/div><\/div><\/div><h3 class=\"post-title\"><a href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/tabuk-pharmaceuticals-expands-strategic-partnership-with-hk-inno-n-to-include-additional-mena-markets-for-k-cab-tegoprazan\/\">Tabuk Pharmaceuticals Expands Strategic Partnership with HK inno.N to Include Additional MENA Markets for K-CAB\u00ae (Tegoprazan)<\/a><\/h3><div class=\"post-content\">Riyadh, Saudi Arabia \u2013 [May 7 2025] \u2014 Tabuk Pharmaceuticals, a leading Saudi pharmaceutical company with a strong regional footprint across the Middle East and North Africa (MENA), announced today the expansion of <\/div><div class=\"post-labels\"><div class=\"post-categories\"><a class=\"post-category-item\" href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/category\/press-releases\/\">Press Releases<\/a><\/div><\/div>    <\/div>\r\n<\/div>\r\n<div class=\"standard-blog-item-wrapper post post-31002 type-post status-publish format-standard has-post-thumbnail hentry category-press-releases\">\r\n    <div class=\"blog-item\">\r\n        <div class=\"post-media-wrapper\"><a href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/tabuk-pharmaceuticals-announces-exclusive-licensing-partnership-with-hanmi-to-introduce-innovative-value-added-medicines-in-the-kingdom-of-saudi-arabia-and-mena-region\/\"><picture><source media=\"(max-width: 575px)\" sizes=\"(max-width: 575px) 575px\" srcset=\"https:\/\/www.tabukpharmaceuticals.com\/wp-content\/uploads\/2025\/04\/\u062a\u0646\u0632\u064a\u0644-12-575x274.jpg 575w\"><source media=\"(max-width: 991px)\" sizes=\"(max-width: 991px) 991px\" srcset=\"https:\/\/www.tabukpharmaceuticals.com\/wp-content\/uploads\/2025\/04\/\u062a\u0646\u0632\u064a\u0644-12-991x472.jpg 991w\"><img decoding=\"async\" alt=\"\u062a\u0646\u0632\u064a\u0644 (12)\" title=\"\u062a\u0646\u0632\u064a\u0644 (12)\" src=\"https:\/\/www.tabukpharmaceuticals.com\/wp-content\/uploads\/2025\/04\/\u062a\u0646\u0632\u064a\u0644-12-1280x638.jpg\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" \/><\/picture><\/a><\/div><div class=\"post-meta-header\"><div class=\"post-meta-items-wrapper\"><div class=\"post-meta-items\"><div class=\"post-meta-item post-meta-item-date\"><a href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/2025\/05\/06\/\">\u0645\u0627\u064a\u0648 6, 2025<\/a><\/div><div class=\"post-meta-item post-meta-item-author\"><a href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/author\/Taha\/\">Taha<\/a><\/div><\/div><\/div><\/div><h3 class=\"post-title\"><a href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/tabuk-pharmaceuticals-announces-exclusive-licensing-partnership-with-hanmi-to-introduce-innovative-value-added-medicines-in-the-kingdom-of-saudi-arabia-and-mena-region\/\">Tabuk Pharmaceuticals Announces Exclusive Licensing Partnership with Hanmi to Introduce Innovative Value-Added Medicines in the Kingdom of Saudi Arabia and MENA Region<\/a><\/h3><div class=\"post-content\">Riyadh \u2013 Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial Group), a leading Saudi pharmaceutical company, today announced an exclusive licensing partnership with Hanmi, a renow<\/div><div class=\"post-labels\"><div class=\"post-categories\"><a class=\"post-category-item\" href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/category\/press-releases\/\">Press Releases<\/a><\/div><\/div>    <\/div>\r\n<\/div>\r\n<div class=\"standard-blog-item-wrapper post post-30999 type-post status-publish format-standard has-post-thumbnail hentry category-press-releases\">\r\n    <div class=\"blog-item\">\r\n        <div class=\"post-media-wrapper\"><a href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/biocon-limited-partners-with-tabuk-pharmaceuticals-to-commercialise-its-glucagon-like-peptide-1glp-1-products-in-the-middle-east-region\/\"><picture><source media=\"(max-width: 575px)\" sizes=\"(max-width: 575px) 575px\" srcset=\"https:\/\/www.tabukpharmaceuticals.com\/wp-content\/uploads\/2025\/04\/\u062a\u0646\u0632\u064a\u0644-11-575x274.jpg 575w\"><source media=\"(max-width: 991px)\" sizes=\"(max-width: 991px) 991px\" srcset=\"https:\/\/www.tabukpharmaceuticals.com\/wp-content\/uploads\/2025\/04\/\u062a\u0646\u0632\u064a\u0644-11-991x472.jpg 991w\"><img decoding=\"async\" alt=\"\u062a\u0646\u0632\u064a\u0644 (11)\" title=\"\u062a\u0646\u0632\u064a\u0644 (11)\" src=\"https:\/\/www.tabukpharmaceuticals.com\/wp-content\/uploads\/2025\/04\/\u062a\u0646\u0632\u064a\u0644-11-1340x638.jpg\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" \/><\/picture><\/a><\/div><div class=\"post-meta-header\"><div class=\"post-meta-items-wrapper\"><div class=\"post-meta-items\"><div class=\"post-meta-item post-meta-item-date\"><a href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/2025\/05\/05\/\">\u0645\u0627\u064a\u0648 5, 2025<\/a><\/div><div class=\"post-meta-item post-meta-item-author\"><a href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/author\/Taha\/\">Taha<\/a><\/div><\/div><\/div><\/div><h3 class=\"post-title\"><a href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/biocon-limited-partners-with-tabuk-pharmaceuticals-to-commercialise-its-glucagon-like-peptide-1glp-1-products-in-the-middle-east-region\/\">Biocon Limited partners with Tabuk Pharmaceuticals to commercialise its Glucagon-like peptide-1 (GLP -1) products in the Middle East region.<\/a><\/h3><div class=\"post-content\">Tabuk Pharmaceuticals Partners with Biocon to Bring GLP-1 Diabetes and Weight Management Therapies to the Middle East Riyadh \u2013 Tabuk Pharmaceutical Manufacturing Company, a fully owned subsidiary of Astra Industrial <\/div><div class=\"post-labels\"><div class=\"post-categories\"><a class=\"post-category-item\" href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/category\/press-releases\/\">Press Releases<\/a><\/div><\/div>    <\/div>\r\n<\/div>            <\/div>\n\n            <div class=\"content-pagination\"><nav class=\"navigation pagination\" role=\"navigation\"><h2 class=\"screen-reader-text\">Pagination<\/h2><div class=\"nav-links\"><span aria-label=\"\u0635\u0641\u062d\u0629 1\" aria-current=\"page\" class=\"page-numbers current\"><span class=\"button-inner\"><\/span>1<\/span>\n<a aria-label=\"\u0635\u0641\u062d\u0629 2\" class=\"page-numbers\" href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/wp-json\/wp\/v2\/pages\/533\/?40538fd-paged=2\"><span class=\"button-inner\"><\/span>2<\/a>\n<a class=\"next page-numbers\" href=\"https:\/\/www.tabukpharmaceuticals.com\/ar\/wp-json\/wp\/v2\/pages\/533\/?40538fd-paged=2\">Next<span class=\"button-inner\"><\/span><span class=\"icon-button-arrow left\"><\/span><span class=\"icon-button-arrow right\"><\/span><\/a><\/div><\/nav><\/div>        <\/div>\n        \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-533","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.tabukpharmaceuticals.com\/ar\/wp-json\/wp\/v2\/pages\/533","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.tabukpharmaceuticals.com\/ar\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.tabukpharmaceuticals.com\/ar\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.tabukpharmaceuticals.com\/ar\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.tabukpharmaceuticals.com\/ar\/wp-json\/wp\/v2\/comments?post=533"}],"version-history":[{"count":0,"href":"https:\/\/www.tabukpharmaceuticals.com\/ar\/wp-json\/wp\/v2\/pages\/533\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.tabukpharmaceuticals.com\/ar\/wp-json\/wp\/v2\/media?parent=533"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}